Literature DB >> 10737120

No genetic association between the LRP receptor and sporadic or late-onset familial Alzheimer disease.

W K Scott1, L H Yamaoka, M P Bass, P C Gaskell, P M Conneally, G W Small, L A Farrer, S A Auerbach, A M Saunders, A D Roses, J L Haines, M A Pericak-Vance.   

Abstract

The low-density lipoprotein receptor-related protein gene (LRP1) is often mentioned as a candidate gene for Alzheimer disease (AD) because of its role as a receptor for apolipoprotein E (apoE), a major genetic risk factor for late-onset familial and sporadic AD. A recent association study of a tetranucleotide repeat polymorphism located 5' to the LRP1 gene detected an increase in the 87 base pair allele in AD cases compared to unaffected controls. Additionally, an independent study involving a genomic screen for genes associated with late-onset AD identified a region as a possible location of a late-onset AD gene on chromosome 12p between D12S373 and D12S390, about 10 cM proximal to LRP1. We examined 144 late-onset multiplex AD families, 436 sporadic AD cases, and 240 controls and found no evidence of linkage or association of LRP1 and AD. Our data indicate that genetic variation of the LRP1 gene is not a major risk factor in the etiology of AD.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 10737120     DOI: 10.1007/s100480050026

Source DB:  PubMed          Journal:  Neurogenetics        ISSN: 1364-6745            Impact factor:   2.660


  11 in total

1.  Fine mapping of the chromosome 12 late-onset Alzheimer disease locus: potential genetic and phenotypic heterogeneity.

Authors:  W K Scott; J M Grubber; P M Conneally; G W Small; C M Hulette; C K Rosenberg; A M Saunders; A D Roses; J L Haines; M A Pericak-Vance
Journal:  Am J Hum Genet       Date:  2000-03       Impact factor: 11.025

Review 2.  Dancing in the dark? The status of late-onset Alzheimer's disease genetics.

Authors:  L Bertram; R E Tanzi
Journal:  J Mol Neurosci       Date:  2001-10       Impact factor: 3.444

3.  LRP-1 variation is not associated with risk of Alzheimer's disease.

Authors:  Katy A Chalmers; Rachel Barker; Peter A Passmore; Francesco Panza; Davide Seripa; Vincenzo Solfrizzi; Seth Love; Jonathan A Prince; Patrick G Kehoe
Journal:  Int J Mol Epidemiol Genet       Date:  2010-02-20

4.  Neuronal apoptosis by apolipoprotein E4 through low-density lipoprotein receptor-related protein and heterotrimeric GTPases.

Authors:  Y Hashimoto; H Jiang; T Niikura; Y Ito; A Hagiwara; K Umezawa; Y Abe; Y Murayama; I Nishimoto
Journal:  J Neurosci       Date:  2000-11-15       Impact factor: 6.167

Review 5.  Evidence for defective retinoid transport and function in late onset Alzheimer's disease.

Authors:  Ann B Goodman; Arthur B Pardee
Journal:  Proc Natl Acad Sci U S A       Date:  2003-02-25       Impact factor: 11.205

6.  An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.

Authors:  Todd L Edwards; Margaret Pericak-Vance; Johnny R Gilbert; Jonathan L Haines; Eden R Martin; Marylyn D Ritchie
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2009-07-05       Impact factor: 3.568

Review 7.  Chasing genes in Alzheimer's and Parkinson's disease.

Authors:  Aida M Bertoli-Avella; Ben A Oostra; Peter Heutink
Journal:  Hum Genet       Date:  2004-03-04       Impact factor: 4.132

8.  Correlation of polymorphism of APOE and LRP genes to cognitive impairment and behavioral and psychological symptoms of dementia in Alzheimer's disease and vascular dementia.

Authors:  Chengzhi Mou; Tao Han; Min Wang; Meng Jiang; Bin Liu; Jia Hu
Journal:  Int J Clin Exp Med       Date:  2015-11-15

9.  Genetic and environmental epidemiology of Alzheimer's disease in arabs residing in Israel.

Authors:  Lindsay A Farrer; Robert P Friedland; Abdalla Bowirrat; Kristin Waraska; Amos Korczyn; Clinton T Baldwin
Journal:  J Mol Neurosci       Date:  2003       Impact factor: 2.866

10.  Receptor-associated protein (RAP) plays a central role in modulating Abeta deposition in APP/PS1 transgenic mice.

Authors:  Guilian Xu; Celeste Karch; Ning Li; Nianwei Lin; David Fromholt; Victoria Gonzales; David R Borchelt
Journal:  PLoS One       Date:  2008-09-08       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.